Market Overview

UPDATE: Hilliard Lyons Initiates Cerner with Long-Term Buy on Technological Competitive Advantage

Related CERN
Cerner to Replace Department of Defense's Anatomic Pathology Laboratory Information System
Healthcare IT Investors: Oppenheimer Just Made Some Waves
Will Cerner's (CERN) Earnings Pull a Surprise in Q2? - Analyst Blog (Zacks)

In a report published Monday, Hilliard Lyons analyst Stephen Turner initiated coverage on Cerner Corporation (NASDAQ: CERN) with a Long-Term Buy rating and $58.00 price target.

In the report, Hilliard Lyons noted, “We believe Cerner has a technological competitive advantage due to the company's sole focus on health care information technology, and its product offering size and scale within the industry. Through this competitive advantage along with government mandates and positive industry trends Cerner has the potential to gain market share, in our opinion. New growth trends beyond Cerner's core Electronic Health Record (EHR) system, Millennium, include physician practice management solutions, population health management and revenue cycle management software & services.”

Cerner Corporation closed on Friday at $47.37.

Latest Ratings for CERN

Jun 2015OppenheimerInitiates Coverage onOutperform
Apr 2015SunTrust Robinson HumphreyDowngradesBuyNeutral
Apr 2015BarclaysMaintainsBuy

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Hilliard Lyons Stephen TurnerAnalyst Color Initiation Analyst Ratings


Related Articles (CERN)

Get Benzinga's Newsletters